Suchergebnisse - "Laracy, Justin C"

PubPharm (14)

1

Teaching Everyone Everywhere All at Once : Leveraging Social Media to Implement a Multisite Fungal Diagnostics Curriculum

enthalten in: Open forum infectious diseases | 2023

von Nematollahi, S. | Tackett, S. | Grieb, S. | +6

2

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

enthalten in: Haematologica | 2023

von Laracy, J. | Yan, J. | Steiger, S. | +14

3

Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants

enthalten in: The Journal of infection | 2023

von Kamboj, M. | Laracy, J. | Usiak, S. | +3

CommentOn: J Infect. 2023 May;86(5):e126-e129. - PMID 36750165

4

Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant

enthalten in: Infection control and hospital epidemiology | 2023

von Laracy, J. | Robilotti, E. | Yan, J. | +4

5

SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease

enthalten in: bioRxiv.org | 2022

von Wang, P. | Liu, L. | Nair, M. | +13

6

SARS-CoV-2 in immunocompromised individuals

enthalten in: Immunity | 2022

von DeWolf, S. | Laracy, J. | Perales, M. | +3

7

Long and persistent COVID-19 in patients with hematologic malignancies : from bench to bedside

enthalten in: Current opinion in infectious diseases | 2022

von Laracy, J. | Kamboj, M. | Vardhana, S.

8

The solid organ transplant recipient with SARS-CoV-2 infection

enthalten in: Current opinion in organ transplantation | 2021

von Laracy, J. | Miko, B. | Pereira, M.

9

Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Gomez-Simmonds, A. | Annavajhala, M. | McConville, T. | +9

10

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

enthalten in: Emerging microbes & infections | 2020

von Wang, P. | Liu, L. | Nair, M. | +15